FDA.reportPublic FDA data

Application 201779

Type
ANDA
Sponsor
GLENMARK GENERICS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ZOLMITRIPTANZOLMITRIPTANTABLET;ORAL2.5MGNoNo
002ZOLMITRIPTANZOLMITRIPTANTABLET;ORAL5MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
68001-249ZolmitriptanZolmitriptanBluePoint LaboratoriesANDACurrent
68001-249ZolmitriptanZolmitriptanBluePoint LaboratoriesANDACurrent
68001-249ZolmitriptanZolmitriptanBluePoint LaboratoriesANDACurrent
68001-250ZolmitriptanZolmitriptanBluePoint LaboratoriesANDACurrent
68001-250ZolmitriptanZolmitriptanBluePoint LaboratoriesANDACurrent
68001-250ZolmitriptanZolmitriptanBluePoint LaboratoriesANDACurrent
68462-497ZolmitriptanZolmitriptanGlenmark Pharmaceuticals Inc.,USAANDACurrent
68462-497ZolmitriptanZolmitriptanGlenmark Pharmaceuticals Inc.,USAANDACurrent
68462-497ZolmitriptanZolmitriptanGlenmark Pharmaceuticals Inc.,USAANDACurrent
68462-497ZolmitriptanZolmitriptanGlenmark Pharmaceuticals ANDACurrent
68462-498ZolmitriptanZolmitriptanGlenmark Pharmaceuticals Inc.,USAANDACurrent
68462-498ZolmitriptanZolmitriptanGlenmark Pharmaceuticals Inc.,USAANDACurrent
68462-498ZolmitriptanZolmitriptanGlenmark Pharmaceuticals Inc.,USAANDACurrent
68462-498ZolmitriptanZolmitriptanGlenmark Pharmaceuticals ANDACurrent